Jain Rita has filed 24 insider transactions across 4 companies since February 2023.
Most recent transaction: a grant/award of 1339 shares of Avalo Therapeutics, Inc. ($AVTX) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Avalo Therapeutics, Inc. | $AVTX | Jain Rita | Not found | A | Stock Option (Right to Buy) | 1339 | $12.13 | 1,339.0000 | 18,133,968 | 9999.99% | 0.01% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | A | Restricted Stock Unit | 4000 | $0.00 | 4,000.0000 | 27,688,470 | 9999.99% | 0.01% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | A | Stock Option (right to buy) | 5500 | $0.00 | 5,500.0000 | 27,688,470 | 9999.99% | 0.02% |
| Jan. 5, 2026 | SAB Biotherapeutics, Inc. | $SABS | Jain Rita | Not found | A | Stock Option (right to buy) | 240000 | $0.00 | 240,000.0000 | 77,863,263 | 9999.99% | 0.31% |
| Dec. 31, 2025 | Avalo Therapeutics, Inc. | $AVTX | Jain Rita | Director | A | Stock Option (Right to Buy) | 1043 | $14.74 | 1,043.0000 | 18,133,968 | 9999.99% | 0.01% |
| Sept. 30, 2025 | Avalo Therapeutics, Inc. | $AVTX | Jain Rita | Director | A | Stock Option (Right to Buy) | 1572 | $0.00 | 1,572.0000 | 10,671,934 | 9999.99% | 0.01% |
| June 17, 2025 | Avalo Therapeutics, Inc. | $AVTX | Jain Rita | Director | A | Stock Option (Right to Buy) | 40200 | $0.00 | 40,200.0000 | 10,671,934 | 9999.99% | 0.38% |
| June 15, 2025 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | M | Restricted Stock Unit | 6030 | $0.00 | 0.0000 | 30,666,781 | 100.00% | 0.02% |
| June 15, 2025 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | M | Common Stock | 7330 | $0.00 | 11,864.0000 | 30,666,781 | 161.67% | 0.02% |
| June 15, 2025 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | M | Restricted Stock Unit | 1300 | $0.00 | 1,300.0000 | 30,666,781 | 50.00% | 0.00% |
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | Jain Rita | Not found | A | Non-Qualified Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 66,383 | 9999.99% | 24.86% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | A | Restricted Stock Unit | 6030 | $0.00 | 6,030.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | A | Stock Option (right to buy) | 16510 | $0.00 | 16,510.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2024 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | M | Restricted Stock Unit | 1300 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 15, 2024 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | M | Common Stock | 4534 | $0.00 | 4,534.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2024 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Not found | M | Restricted Stock Unit | 3234 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | Jain Rita | Not found | A | Non-Qualified Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 58,871 | 9999.99% | 28.03% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Director | A | Stock Option (right to buy) | 16510 | $0.00 | 16,510.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Director | A | Restricted Stock Unit | 6030 | $0.00 | 6,030.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Director | A | Restricted Stock Unit | 3234 | $0.00 | 3,234.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Director | A | Stock Option (right to buy) | 10600 | $0.00 | 10,600.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Director | A | Stock Option (right to buy) | 8015 | $0.00 | 8,015.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | ANAPTYSBIO, INC | $ANAB | Jain Rita | Director | A | Restricted Stock Unit | 3900 | $0.00 | 3,900.0000 | 0 | 9999.99% | 0.00% |
| Feb. 16, 2023 | Celldex Therapeutics, Inc. | $CLDX | Jain Rita | Director | A | Non-Qualified Stock Option (right to buy) | 17100 | $0.00 | 17,100.0000 | 46,888 | 9999.99% | 36.47% |